Effects of reactive oxygen and nitrogen metabolites on eotaxin-induced eosinophil chemotactic activity in vitro

American Journal of Respiratory Cell and Molecular Biology

Volumn 22, Issue 1, 2000, Pages 61-67

  Sato, Etsuro ^a,b,c   Simpson, Keith L ^a,b,c   Grisham, Matthew B ^a,b,c   Koyama, Sekiya ^a,b,c   Robbins, Richard A ^a,b,c,d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034077641     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.22.1.3644     Document Type: Article

References (48)

1. 1. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449-456.
2. 2. Griffiths-Johnson, D. A., P. D. Collins, A. G. Rossi, P. J. Jose, and T. J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197:1167-1172.
3. 3. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881-887.
4. 4. Ponath, P. D., S. Qin, D. J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J. A. Gonzalo, W. Newman, J. C. Gutierrez-Ramos, and C. R. Mackayk. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
5. 5. Lamkhioued, B., P. M. Renzi, S. Abi-Younes, E. A. Garcia-Zepada, Z. Allakhverdi, O. Ghaffar, M. D. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:4593-4601.
6. 6. Robbins, R. A. 1997. Nitric oxide. In Asthma. P. J. Barnes, M. M. Grunstein, A. R. Leff, and A. J. Woolcock, editors. Lippincott-Raven, Philadelphia. 695-705.
7. 7. Calhoun, W. J., H. E. Reed, D. R. Moest, and C. A. Stevens. 1992. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 145:317-325.
8. 8. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
9. 9. Jarjour, N. N., W. W. Bussee, and W. J. Calhoun. 1992. Enahanced production of oxygen radicals in nocturnal asthma. Am. Rev. Respir. Dis. 146: 905-911.
10. 10. Joseph, B. Z., J. M. Routes, and L. Borish. 1993. Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors. Inflammation 17:361-370.
11. 11. Saleh, D., P. Ernst, S. Lim, P. J. Barnes, and A. Giaid. 1998. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 12:929-937.
12. 12. Radi, R., T. P. Cosgrove, J. S. Beckman, and B. A. Freeman. 1993. Peroxynitrite-induced luminol chemiluminescence. Biochem. J. 290:51-57.
13. 13. Ischiropoulos, H., and A. B. al-Mehdi. 1995. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364:279-282.
14. 14. Hansel, T. T., I. J. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145:105-110.
15. 15. Harvath, L., W. Falk, and E. J. Leonard. 1980. Rapid quantification of neutrophil chemotaxis: use of polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J Immunol. Methods 37:39-45.
16. 16. Snyderman, R., H. Gewurz, and S. E. Mergenhagen. 1968. Interactions of the complement system with endotoxic lipopolysaccharide: generation of a factor chemotactic for polymorphonuclear leukocytes. J. Exp. Med. 128: 259-275.
17. 17. Wink, D. A., J. A. Cook, D. Christodoulou, M. C. Krishna, R. Pacelli, S. Kim, W. DeGraff, J. Gamson, Y. Vodovotz, A. Russo, and J. B. Mitchell. 1997. Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1:88-94.
18. 18. Fridovich, I. 1970. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J. Biol. Chem. 245:4053-4057.
19. 19. Holm, P., H. Kankaanranta, T. Metsa-Ketela, and E. Moilanen. 1998. Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur. J. Pharmacol. 346:97-102.
20. 20. Jones, K. L., T. W. Bryan, P. A. Jinkins, K. L. Simpson, M. B. Grisham, M. W. Owens, S. A. Milligan, B. A. Markewitz, and R. A. Robbins. 1998. Superoxide released from neutrophils cause a reduction in nitric oxide gas. Am. J. Physiol. 275:L1120-L1126.
21. 21. Darley-Usmar, V. M., N. Hogg, V. J. O'Leary, M. T. Wilson, and S. Moncada. 1992. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. 17:9-20.
22. 22. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. Wells, D. Li, P. K. Jeffery, D. A. Griffiths-Johnson, T. J. Williams, and P. J. Jose. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601-612.
23. 23. Mayer, B., S. Pfeiffer, A. Schrammel, D. Koesling, K. Schmidt, and F. Brunner. 1998. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J. Biol. Chem. 273:3264-3270.
24. 24. Huie, R. E., and S. Padmaja. 1993. The reaction of NO with superoxide. Free Radic. Res. Commun. 18:195-199.
25. 25. Pryor, W. A., and G. L. Squadrito. 1995. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268;L699-L722.
26. 26. Salgo, M. G., E. Bermudez, G. L. Squadrito, and W. A. Pryor. 1995. Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes. Arch. Biochem. Biophys. 322:500-505.
27. 27. Rubbo, H., R. Radi, M. Trujillo, R. Telleri, B. Kalyanaraman, S. Barnes, M. Kirk, and B. A. Freeman. 1994. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269:26066-26075.
28. 28. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitirite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620-1624.
29. 29. Ishiropooulos, H., I., Zhu, J. Chen, M. Tsai, J.C. Martin, Smith, and J. S. Beckman. 1992. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:431-437.
30. 30. van der Vliet, A., J. P. Eiserich, C. A. O'Neill, B. Halliwell, and C. E. Cross. 1995. Tyrosine modification by reactive nitrogen species: a closer look. Arch. Biochem. Biophys. 319:341-349.
31. 31. Royall, J. A., N. W. Kooy, and J. S. Beckman. 1995. Nitric oxide-related oxidants in acute lung injury. New Horiz. 3:113-122.
32. 32. Haddad, I. Y., G. Pataki, P. Hu, C. Galliani, J. S. Beekman, and S. Matalon. 1994. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94:2407-2413.
33. 33. Thom, S. R., S. T. Ohnishi, D. Fisher, Y. A. Xu, and H. Ischiropoulos. 1999. Pulmonary vascular stress from carbon monoxide. Toxicol. Appl. Pharmacol. 154:12-19.
34. 34. Rohn, T. T., and M. T. Quinn. 1998. Inhibition of peroxynitrite-mediated tyrosine nitration by a novel pyrrolopyrimidine antioxidant. Eur. J. Pharmacol. 353:329-336.
35. 35. Denicola, A., J. M. Souza, R. M. Gatti, O. Augusto, and R. Radi. 1995. Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: role of the hydroxamic groups. Free Radic. Biol. Med. 19:11-19.
36. 36. Bath, P. M. 1993. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Eur. J. Clin. Pharmacol. 45:53-58.
37. 37. Moilanen, E., P. Vuorinen, H. Kankaanranta, T. Metsa-Ketela, and H. Vapaatalo. 1993. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol. 109:852-858.
38. 38. Kaplan, S. S., T. Billiar, R. D. Curran, U. E. Zdziarski, R. L. Simmons, and R. E. Basford. 1989. Attenuation of chemotaxis with NG-monomethyl-L-arginine: a role for cyclic GMP. Blood 74:1885-1887.
39. 39. Belenky, S. N., R. A. Robbins, S. I. Rennard, G. L. Gossman, K. J. Nelson, and I. Rubinstein. 1993. Inhibitors of nitric oxide synthase attenuate neutrophil chemotaxis in vitro. J. Lab. Clin. Med. 122:388-394.
40. 40. Belenky, S. N., R. A. Robbins, and I. Rubinstein. 1993. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leukoc. Biol. 53:498-503.
41. 41. Steitz, S. A., H. Hasegawa, S. L. Chiang, R. R. Cobb, M. A. Castro, T. J. Lobl, M. Yamada, E. Lazarides, and P. M. Cardarelli. 1998. Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis. FEBS Lett. 430:158-164.
42. 42. Zhang, Y. J., B. J. Rutledge, and B. J. Rollins. 1994. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J. Biol. Chem. 269:15918-15924.
43. 43. Crump, M. P., K. Rajarathnam, K. S. Kim, I. Clark-Lewis, and B. D. Sykes. 1998. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J. Biol. Chem. 273:22471-22479.
44. 44. Vogt, W. 1995. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic. Biol. Med. 18:93-105.
45. 45. Alvarez, B., H. Rubbo, M. Kirk, S. Barnes, B. A. Freeman, and R. Radi. 1996. Peroxynitrite-dependent tryptophan nitration. Chem. Res. Toxicol. 9:390-396.
46. 46. Gow, A. J., D. G. Buerk, and H. Ischiropoulos. 1997. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J. Biol. Chem. 272: 2841-2845.
47. 47. Eiserich, J. P., M. Hristova, C. E. Cross, A. D. Jones, B. A. Freeman, B. Halliwell, and A. van Der Vliet. 1998. Formation of nitric oxide-derived inflammatory oxidants by mycloperoxidase in neutrophils. Nature 391: 393-397.
48. 48. Huber, R. E., L. A. Edwards, and T. J. Carne. 1989. Studies on the mechanism of the iodination of tyrosine by lactoperoxidase. J. Biol. Chem. 264: 1381-1386.